NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDRanibizumab 10mg/ml intravitreal injection
(Intravitreal Injection ) 		Eye, Subfoveal choroidal neovascularisation, 11.08.02
Non Formulary items found
Status Description Section
DNPLutein antioxidant supplements  Nutrition and blood, Multivitamin preparations, 09.06.07
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Aflibercept Aflibercept [Specialist Drug] Eye, Antineoplastic Drugs, Antineoplastics, Other
Retinal Disorders, Macular Degeneration
Aflibercept Aflibercept [Specialist Drug] Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Degeneration
Brolucizumab Brolucizumab [Specialist Drug] Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Degeneration
Faricimab  Faricimab [Specialist Drug] Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Degeneration
Ranibizumab  Ranibizumab [Specialist Drug] Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Degeneration
Verteporfin Verteporfin [Specialist Drug] Eye, Photosensitisers
Retinal Disorders, Macular Degeneration
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1022: Bevacizumab gamma for treating wet age-related macular degeneration
NICE TA155: Macular degeneration (age-related) ranibizumab
NICE TA294: Macular degeneration (wet age-related) - aflibercept
NICE TA672: Brolucizumab for treating wet age-related macular degeneration
NICE TA800 Faricimab for treating wet age-related macular degeneration